Business

Sagent Pharmaceuticals 1Q revenues up 17 pct.

Posted May 06, 2015 1:00 am

Globe Newswire

SCHAUMBURG - Specialty drugmaker Sagent Pharmaceuticals reported revenues in the first quarter of 2015 rose 17 percent, primarily from increase demand and its recent acquisition of Omega Laboratories.

Revenue for the quarter was to a $82.6 million, compared to $70.9 million in the first quarter of 2014. The increase was driven primarily by the $7.4 million from the addition of Omega last October, according to the company.

"We are very pleased to report a strong start to the year, with solid revenue performance driven by broad demand across our diverse product offerings including those marketed in Canada by Omega," said Sagent President Michael Logerfo. "We remain focused on investing efficiently to enhance our deep product pipeline and expanding the reach of the business through our network of partners, suppliers, and customers."

Article Comments

Article Categories
Business Communities Health Schaumburg

Article Comments

Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.